INS and Hypoglycemia: The results showed that the course of disease, BMI, fasting C-peptide and creatinine were independent risk factors for hypoglycemia after intensive insulin therapy (P<0.05), while instantaneous scanning glucose test system monitoring and glucometer monitoring were protective factors (P<0.05) (Table 4).